These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25448364)

  • 1. Quantification of the effect of Lipo-PGE1 on angiogenesis.
    Eo S; Kwon C; Lee H; Cho S; Kim J; Baek G; Yeo J; Lim C
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):104-12. PubMed ID: 25448364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of lipo-prostaglandin E1 on axial pattern flaps in rabbits.
    Kuwahara H; Fazhi Q; Sugihara T; Ohura T; Igawa H; Yamamoto Y
    Ann Plast Surg; 1995 Dec; 35(6):620-6. PubMed ID: 8748345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
    Hasegawa H; Ichioka S
    J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lipo-prostaglandin E1 on random pattern flaps in rabbits.
    Kuwahara H; Sugihara T; Ohura T; Igawa H; Yamamoto Y
    Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):23-8. PubMed ID: 8711438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumlation of lipoprostaglandin E1 at the anastomotic region after systemic application.
    Okochi M; Ueda K; Kajikawa A
    Microsurgery; 2011 Jul; 31(5):382-7. PubMed ID: 21618280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXC chemokine receptor 4 is essential for Lipo-PGE1-enhanced migration of human dermal fibroblasts.
    Yang Y; Shim SK; Kim HA; Seon M; Yang E; Cho D; Bang SI
    Exp Dermatol; 2012 Jan; 21(1):75-7. PubMed ID: 22151395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication.
    Ishihara T; Yamashita Y; Takasaki N; Yamamoto S; Hayashi E; Tahara K; Takenaga M; Yamakawa N; Ishihara T; Kasahara T; Mizushima T
    J Pharm Pharmacol; 2013 Aug; 65(8):1187-94. PubMed ID: 23837586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific augmentation of plantar skin blood flow by lipo-PGE1 assessed in tetrodotoxin- and N(G)-nitro-L-arginine-treated rats.
    Chino D; Akimaru S; Kataha K; Ishii K; Nakayama K
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):630-7. PubMed ID: 10774795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of alprostadil (prostaglandin E1) incorporated in lipid microspheres of soybean oil on intimal hyperplasia following balloon injury in rabbits.
    Kunihara M; Tsuchida K; Kaneko K; Suga H; Hasegawa T; Mochizuki S; Kawai K; Shiga A; Yamaguchi T
    Arzneimittelforschung; 2002; 52(5):358-64. PubMed ID: 12087920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An investigation of the protective effect of prostaglandin E1 liposome on acute lung injury in pig].
    Xiao J; Zhong R; Shi SY; Ye GS; Xia BJ; Wang CM; Huang W
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jun; 20(6):345-8. PubMed ID: 18549714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
    Tobari S; Ikeda Y; Takami H
    J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between non-ionic contrast medium and prostaglandin E1 incorporated in lipid microspheres: in-vitro comparative study of direct and non-direct mixing.
    Hayashi H; Uchiyama N; Kawamata H; Takagi R; Abe Y; Kumazaki T
    Radiat Med; 2000; 18(4):219-25. PubMed ID: 11246996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of prostaglandin E1 on activation of hepatic stellate cells in rabbits with schistosomiasis.
    Zou WL; Yang Z; Zang YJ; Li DJ; Liang ZP; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):176-81. PubMed ID: 17374578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage].
    Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988; 16(5 Suppl):509-15. PubMed ID: 3399005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
    Moriuchi-Murakami E; Yamada H; Ishii O; Kikukawa T; Igarashi R
    J Rheumatol; 2000 Oct; 27(10):2389-96. PubMed ID: 11036835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on antinephritic effect of Lipo PGE1 (2). The suppressive action of Lipo PGE1 on the development of accelerated passive Heymann nephritis in rats].
    Nagao T; Ito M; Suzuki Y
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1071-9. PubMed ID: 1725534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipo-prostaglandin E1 increases immediate arterial maximal flow velocity of free flap in patients undergoing reconstructive surgery.
    Jin SJ; Suh HP; Lee J; Hwang JH; Hong JPJ; Kim YK
    Acta Anaesthesiol Scand; 2019 Jan; 63(1):40-45. PubMed ID: 30058113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
    Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and hemodynamic effects of lipo PGE1 in cerebral infarction].
    Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988 Jun; 16(7):819-26. PubMed ID: 3221965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous prostaglandin E1 on experimental flaps.
    Suzuki S; Isshiki N; Ogawa Y; Nishimura R; Kurokawa M
    Ann Plast Surg; 1987 Jul; 19(1):49-53. PubMed ID: 3631860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.